|
Jul 18
|
Buy These 5 Low-Leverage Stocks Amid Impressive Retail Sales Data
|
|
Jul 17
|
This Pick Withstood the GLP-1 Challenge. Stick With the Stock.
|
|
Jul 16
|
Is Akebia Therapeutics (AKBA) Stock Outpacing Its Medical Peers This Year?
|
|
Jul 15
|
2 Reasons to Watch RMD and 1 to Stay Cautious
|
|
Jul 9
|
Semler Scientific Stock Gets Relative Strength Rating Upgrade
|
|
Jul 1
|
Resmed to Report Fourth Quarter Fiscal 2025 Earnings on July 31, 2025
|
|
Jul 1
|
ResMed (NYSE:RMD) Could Become A Multi-Bagger
|
|
Jun 30
|
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
|
|
Jun 26
|
Zacks.com featured highlights Sprouts Farmers Market, Adobe, GE Aerospace and ResMed
|
|
Jun 25
|
All You Need to Know About ResMed (RMD) Rating Upgrade to Buy
|
|
Jun 25
|
Scoop Up These 4 GARP Stocks to Receive Handsome Returns
|
|
Jun 18
|
ResMed’s Q1 Earnings Call: Our Top 5 Analyst Questions
|
|
May 23
|
ResMed (RMD) Up 4% Since Last Earnings Report: Can It Continue?
|
|
May 23
|
Is it Worth Retaining ResMed Stock in Your Portfolio Now?
|
|
May 23
|
1 Surging Stock with Exciting Potential and 2 to Avoid
|
|
May 21
|
Morgan Stanley sees ‘modest’ earnings impact to ResMed from Apnimed
|
|
May 20
|
1 Unpopular Stock that Should Get More Attention and 2 to Brush Off
|
|
May 15
|
Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025
|
|
May 15
|
Patient Monitoring Stocks Q1 Teardown: ResMed (NYSE:RMD) Vs The Rest
|
|
Apr 8
|
Strength Seen in ResMed (RMD): Can Its 3.8% Jump Turn into More Strength?
|